Cannabis
Stock News: The Hydropothecary Corporation (TSX VENTURE: $THCX) Receives
License to Sell Cannabis Oil
GATINEAU, QC - March 30, 2017
(Investorideas.com Newswire) The Hydropothecary Corporation (TSX VENTURE: THCX)
(the "Company"), a licensed producer and distributor of medical
cannabis, is pleased to announce it has received an amendment to its licence
from Health Canada under the Access to Cannabis for Medical Purposes
Regulations (Canada) (the "ACMPR") to include the sale of cannabis
oils from its facility in Gatineau, QC. The Company's license under the ACMPR
was amended from production only and provides the Company with the ability to
sell cannabis oil products to registered patients under the ACMPR along with
its current dried medical cannabis products.
The Company received an amendment to
its licence under the ACMPR to produce cannabis oils in August 2015 and has
been focused on the development of a new innovative oil product line. In
anticipation of this approval to sell cannabis oil extracts, the Company has
been producing cannabis oil and extracts. Sales are anticipated to begin late
Spring 2017.
"This is another significant
milestone in the Hydropothecary growth story and provides our clients with yet
another way in which to consume their medicinal cannabis without smoking"
said Sebastien St-Louis, Co-Founder and Chief Executive Officer.
About The Hydropothecary
Corporation
The Hydropothecary Corporation is an
authorized licensed producer and distributor of medical marijuana licensed by
Health Canada under the Access to Cannabis for Medical Purposes Regulations
(Canada). Hydropothecary provides naturally grown and rigorously tested medical
marijuana of uncompromising quality. Hydropothecary's branding, marijuana
product offering, patient service standards and product pricing are consistent
with THC's positioning as a premium brand for a legal source for medical
marijuana within this new marketplace. In addition to medical marijuana
production and sales, Hydropothecary explores various research and development
opportunities for cannabinoid extracts, drugs and combinatory chemistry. In
addition, the company is investigating the development and patenting of novel
technologies related to medical marijuana, as well as the import and export of
medical marijuana.
Forward-Looking Information
This press release contains
forward-looking information based on current expectations.
Statements about market making
activities and TSXV approvals, among others, are forward-looking information.
These statements should not be read as guarantees of future performance or
results. Such statements involve known and unknown risks, uncertainties and
other factors that may cause actual results, performance or achievements to be
materially different from those implied by such statements. The Company assumes
no responsibility to update or revise forward-looking information to reflect new
events or circumstances unless required by law.
Neither the TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in the policies of
the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy
of this release.
For further
information, please contact:
Sebastien St-Louis
Chief Executive Officer
The Hydropothecary Corporation
1-866-438-THCX (8429)
invest@THCX.com
Chief Executive Officer
The Hydropothecary Corporation
1-866-438-THCX (8429)
invest@THCX.com
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment